Kimberly-Clark Corporation, together with its subsidiaries, manufactures and markets personal care and consumer tissue products worldwide. It operates through three segments: Personal Care, Consumer Tissue, and K-C Professional. The Personal Care segment offers disposable diapers, swimpants, training and youth pants, baby wipes, feminine and incontinence care products, and other related products under the Huggies, Pull-Ups, Little Swimmers, GoodNites, DryNites, Sweety, Kotex, U by Kotex, Intimus, Depend, Plenitud, Softex, Poise, and other brand names. The Consumer Tissue segment provides facial and bathroom tissues, paper towels, napkins, and related products under the Kleenex, Scott, Cottonelle, Viva, Andrex, Scottex, Neve, and other brand names. The K-C Professional segment offers wipers, tissues, towels, apparel, soaps, and sanitizers under the Kleenex, Scott, WypAll, Kimtech, and KleenGuard brands. The company sells household use products directly to supermarkets, mass merchandisers, drugstores, warehouse clubs, variety and department stores, and other retail outlets, as well as through other distributors and e-commerce; and away-from-home use products directly to manufacturing, lodging, office building, food service, and public facilities, as well as through distributors and e-commerce. Kimberly-Clark Corporation was founded in 1872 and is headquartered in Dallas, Texas.

Kimberly-Clark Corporation

Revenue

EBIT

EBITDA

CapEx

Net Interest Income

Assets

Adjusted EBITDA

Gross Profit

Adjusted Net Income

Net Revenue

Net Income

Average Assets

Adjusted EBIT

Adjusted Revenue

Adjusted EBT

Adjusted Funds From Operations

North America (NA) Capital Spending

North America (NA) Capital Spending % Chg.

North America (NA) Capital Spending Common Size

International Personal Care (IPC) Capital Spending

International Personal Care (IPC) Capital Spending % Chg.

International Personal Care (IPC) Capital Spending Common Size

International Family Care & Professional (IFP) Capital Spending

International Family Care & Professional (IFP) Capital Spending % Chg.

International Family Care & Professional (IFP) Capital Spending Common Size

Corporate & Other Capital Spending

Corporate & Other Capital Spending % Chg.

Corporate & Other Capital Spending Common Size

Other Capital Expenditures

Other Capital Expenditures % Chg.

Other Capital Expenditures Common Size

Total Capital Expenditures

Total Capital Expenditures Common Size

Total Capital Expenditures % Chg.

Capital Expenditures

Personal Care Capital Spending

Personal Care Capital Spending % Chg.

Personal Care Capital Spending Common Size

Consumer Tissue Capital Spending

Consumer Tissue Capital Spending % Chg.

Consumer Tissue Capital Spending Common Size

K-C Professional Capital Spending

K-C Professional Capital Spending % Chg.

K-C Professional Capital Spending Common Size

North America (NA) Operating Profit

North America (NA) Operating Profit % Chg.

North America (NA) Operating Profit Common Size

International Personal Care (IPC) Operating Profit

International Personal Care (IPC) Operating Profit % Chg.

International Personal Care (IPC) Operating Profit Common Size

International Family Care & Professional (IFP) Operating Profit

International Family Care & Professional (IFP) Operating Profit % Chg.

International Family Care & Professional (IFP) Operating Profit Common Size

Corporate & Other Operating Profit

Corporate & Other Operating Profit % Chg.

Corporate & Other Operating Profit Common Size

Total EBIT

Total EBIT Common Size

Total EBIT % Chg.

Personal Care Operating Profit

Personal Care Operating Profit % Chg.

Personal Care Operating Profit Common Size

Consumer Tissue Operating Profit

Consumer Tissue Operating Profit % Chg.

Consumer Tissue Operating Profit Common Size

K-C Professional Operating Profit

K-C Professional Operating Profit % Chg.

K-C Professional Operating Profit Common Size

Corporate & Other Operating Profit (Pre-FY2024 Reporting)

Corporate & Other Operating Profit (Pre-FY2024 Reporting) % Chg.

Corporate & Other Operating Profit (Pre-FY2024 Reporting) Common Size

Other EBIT

Other EBIT % Chg.

Other EBIT Common Size

Organic Net Sales Growth

Organic Net Sales Growth % Chg.

Key Performance Indicators

North America (NA) Revenue

North America (NA) Revenue % Chg.

North America (NA) Revenue Common Size

International Personal Care (IPC) Revenue

International Personal Care (IPC) Revenue % Chg.

International Personal Care (IPC) Revenue Common Size

International Family Care & Professional (IFP) Revenue

International Family Care & Professional (IFP) Revenue % Chg.

International Family Care & Professional (IFP) Revenue Common Size

Total Revenue

Total Revenue Common Size

Total Revenue % Chg.

Personal Care Revenue

Personal Care Revenue % Chg.

Personal Care Revenue Common Size

Consumer Tissue Revenue

Consumer Tissue Revenue % Chg.

Consumer Tissue Revenue Common Size

K-C Professional Revenue

K-C Professional Revenue % Chg.

K-C Professional Revenue Common Size

Corporate & Other Revenue

Corporate & Other Revenue % Chg.

Corporate & Other Revenue Common Size

Revenue	Sep '25	Jun '25
North America (NA) Revenue	10,834	10,855
International Personal Care (IPC) Revenue	5,630	5,603
Total Revenue	18,879	19,681

Revenue	Sep '25	Jun '25
Personal Care Revenue	—	—
Consumer Tissue Revenue	—	—
K-C Professional Revenue	—	—
Corporate & Other Revenue	—	—
Total Revenue	18,879	19,681

EBIT	Sep '25	Jun '25
North America (NA) Operating Profit	2,521	2,522
International Personal Care (IPC) Operating Profit	752	739
Corporate & Other Operating Profit	-970	-553
Total EBIT	2,646	3,179

EBIT	Sep '25	Jun '25
Personal Care Operating Profit	—	—
Consumer Tissue Operating Profit	—	—
K-C Professional Operating Profit	—	—
Corporate & Other Operating Profit (Pre-FY2024 Reporting)	—	—
Other EBIT	—	—
Total EBIT	2,646	3,179